[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bioaffinity Technologies Inc (BIAF)

Bioaffinity Technologies Inc (BIAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,305
  • Shares Outstanding, K 4,743
  • Annual Sales, $ 6,160 K
  • Annual Income, $ -14,910 K
  • EBIT $ -9 M
  • EBITDA $ -10 M
  • 60-Month Beta -1.05
  • Price/Sales 0.38
  • Price/Cash Flow N/A
  • Price/Book 0.63
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -5.26
  • Most Recent Earnings $-0.64 on 08/07/26
  • Next Earnings Date 11/13/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4573 +3.94%
on 08/11/26
0.7700 -38.27%
on 07/13/26
-0.2913 (-38.00%)
since 07/10/26
3-Month
0.4573 +3.94%
on 08/11/26
2.1750 -78.15%
on 06/02/26
-1.4047 (-74.72%)
since 05/12/26
52-Week
0.4573 +3.94%
on 08/11/26
13.5000 -96.48%
on 09/15/25
-7.7417 (-94.22%)
since 08/12/25

Most Recent Stories

More News
bioAffinity Technologies Reports Second Quarter 2026 Results and Continued Strong Commercial Momentum for CyPath® Lung

CyPath Lung test volume increased 216% year over year in Q2 2026 Company drives physician adoption of CyPath Lung and advances longitudinal clinical...

BIAF : 0.4753 (-2.20%)
BIAFW : 0.0600 (-14.29%)
bioAffinity Technologies Publishes New Clinical Framework Addressing Growing Market for Pulmonary Nodule Risk Stratification and Early Lung Cancer Detection Using CyPath® Lung

Comprehensive clinical review outlines specialty-specific approaches for integrating the test’s lung microenvironment analysis into diagnostic pathway ...

BIAF : 0.4753 (-2.20%)
BIAFW : 0.0600 (-14.29%)
bioAffinity Technologies and Pictor®, Inc. Partner to Develop and Commercialize bioAffinity’s Diagnostics for Asthma and COPD

Collaboration increases laboratory throughput and reduces costs for personalized testing for asthma and COPD, which affect more than 40 million Americans and 650 million people worldwide ...

BIAF : 0.4753 (-2.20%)
BIAFW : 0.0600 (-14.29%)
bioAffinity Technologies’ Quarterly CyPath® Lung Sales Double to New Record as Commercial Momentum Continues

CyPath® Lung sales volume for Q2 2026 grows more than 200% year-over-year and 30% over record-breaking prior quarter Growth in Q2 driven by increasing utilization among...

BIAF : 0.4753 (-2.20%)
BIAFW : 0.0600 (-14.29%)
bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells

Research suggests a potential topical treatment for common skin cancers, squamous cell and basal cell carcinoma Findings will be presented at 2026 RNA...

BIAF : 0.4753 (-2.20%)
BIAFW : 0.0600 (-14.29%)
bioAffinity Technologies Announces Closing of $3.2 Million Offering

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and...

BIAF : 0.4753 (-2.20%)
BIAFW : 0.0600 (-14.29%)
bioAffinity Technologies Announces Pricing of $3.2 Million Offering

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and...

BIAF : 0.4753 (-2.20%)
BIAFW : 0.0600 (-14.29%)
bioAffinity Technologies Announces Program to Advance Veteran Lung Health: Philips, bioAffinity Technologies and 4DMedical Highlight New Approaches to Lung Health Screening for U.S. Veterans

Expert panel will share real-world case studies to demonstrate how mobile CT screening, noninvasive CyPath® Lung testing, and comprehensive functional lung imaging can reduce cost while improving access,...

BIAF : 0.4753 (-2.20%)
BIAFW : 0.0600 (-14.29%)
Multidisciplinary Physician Panel to Share Real-World Benefits of bioAffinity Technologies’ Noninvasive CyPath Lung Cancer Test in Upcoming Society for Advanced Bronchoscopy Webinar

Interventional pulmonologist, medical oncologist and thoracic surgeon will discuss how CyPath® Lung results have made a critical difference in their practices ...

BIAF : 0.4753 (-2.20%)
BIAFW : 0.0600 (-14.29%)
bioAffinity Technologies Announces Notification of Mexico Patent Allowance Covering Novel Lung Cancer Detection Methods Using CyPath® Lung Technology

Strong intellectual property portfolio helps build shareholder value Patent strategy protects CyPath ® Lung’s flow...

BIAF : 0.4753 (-2.20%)
BIAFW : 0.0600 (-14.29%)

Business Summary

bioAffinity Technologies Inc. is a cancer diagnostics company which develops noninvasive, early-stage diagnostics to detect cancer and diseases of the lung and is researching targeted therapies to treat cancer. bioAffinity Technologies Inc. is based in SAN ANTONIO.

See More

Key Turning Points

3rd Resistance Point 0.5473
2nd Resistance Point 0.5235
1st Resistance Point 0.5048
Last Price 0.4753
1st Support Level 0.4623
2nd Support Level 0.4385
3rd Support Level 0.4198

See More

52-Week High 13.5000
Fibonacci 61.8% 8.5177
Fibonacci 50% 6.9787
Fibonacci 38.2% 5.4396
Last Price 0.4753
52-Week Low 0.4573

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.